Breaking News

Tjoapack Receives Investment from Ampersand

Dexter Tjoa takes over as the new CEO

By: Contract Pharma

Contract Pharma Staff

Tjoapack Netherlands B.V., a global contract packaging organization (CPO) for the pharmaceutical industry, has received a majority investment from Ampersand Capital Partners, a private equity firm that specializes in partnering with entrepreneur-led healthcare companies. Ampersand’s investment will be used to expand Tjoapack’s capabilities to meet growing industry demand for high quality pharmaceutical packaging services across different dosage forms.   In conjunction with the deal, Dexter Tjoa,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters